Report flags spike in kids taking antipsychotics

‘Concerning’ increase may be due to prescription shopping and off-label use, says PBAC

Prescription shopping and off-label use may be behind a rise of atypical antipsychotic use in Australian children, says a Pharmaceutical Benefits Advisory Committee (PBAC) report.

The report by PBAC’s drug use subcommittee shows an overall 54% increase in PBS prescriptions of risperidone, quetiapine and olanzapine between 2008 and 2011.